Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q1 2021?

148 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 54,835,912
Total 13F value: $1,532,629,456
Share change: +2,029,433
Put/Call ratio: 97%
SEC-reported price per share: $27.95
Number of holders: 148
Value change: +$56,326,804
Number of buys: 72
Number of sells: 67
Shares outstanding: 104,661,494

Security key

761330109

Report period

Q1 2021

Institutions

148

Top holders

RVNC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Revance Therapeutics, Inc. SEC filings Revance Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 761330109

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BlackRock Finance, Inc.

Disclosed value leader

BlackRock Finance, Inc.

Comparable rows

15/15

Latest evidence

31 Dec 2020

13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.

Comparable ownership Top 5

BlackRock Finance, Inc. 4.8%

JPMORGAN CHASE & CO 4.1%

Essex Woodlands Management, Inc. 3.2%

WELLINGTON MANAGEMENT GROUP LLP 3.1%

VANGUARD GROUP INC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock Finance, Inc.	13F Company 13F	4.8%	$142,051,000 5,012,352 shares	—	31 Dec 2020
JPMORGAN CHASE & CO	13F Company 13F	4.1%	$122,600,000 4,326,053 shares	—	31 Dec 2020
Essex Woodlands Management, Inc.	13F Company 13F	3.2%	$94,714,000 3,342,047 shares	—	31 Dec 2020
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	3.1%	$92,619,000 3,268,117 shares	—	31 Dec 2020
VANGUARD GROUP INC	13F Company 13F	3.1%	$91,827,000 3,240,171 shares	—	31 Dec 2020
ALLIANCEBERNSTEIN L.P.	13F Company 13F	2.9%	$86,888,000 3,065,904 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

148

54,835,912

Rows available

148

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q3 2025 Across Filers

Q3 2025 holders

Q1 2021 holders

148

Holder diff

147

Investor	Q3 2025 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q3 2025 value	Q1 2021 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend